EIF2B5

Revision as of 16:55, 4 September 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search


Eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa
Identifiers
Symbols EIF2B5 ; EIF-2B; CACH; CLE; EIF2Bepsilon; LVWM
External IDs Template:OMIM5 Template:MGI HomoloGene2903
RNA expression pattern
More reference expression data
Orthologs
Template:GNF Ortholog box
Species Human Mouse
Entrez n/a n/a
Ensembl n/a n/a
UniProt n/a n/a
RefSeq (mRNA) n/a n/a
RefSeq (protein) n/a n/a
Location (UCSC) n/a n/a
PubMed search n/a n/a

Eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa, also known as EIF2B5, is a human gene.[1]


References

  1. "Entrez Gene: EIF2B5 eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa".

Further reading

  • Leegwater PA, Pronk JC, van der Knaap MS (2003). "Leukoencephalopathy with vanishing white matter: from magnetic resonance imaging pattern to five genes". J. Child Neurol. 18 (9): 639–45. PMID 14572143.
  • Chaudhri MA, Crawford AC (1991). "Carbon determination in human teeth by activation with He-3 ions". Biological trace element research. 26-27: 521–7. PMID 1704758.
  • Welsh GI, Miyamoto S, Price NT; et al. (1996). "T-cell activation leads to rapid stimulation of translation initiation factor eIF2B and inactivation of glycogen synthase kinase-3". J. Biol. Chem. 271 (19): 11410–3. PMID 8626696.
  • Asuru AI, Mellor H, Thomas NS; et al. (1996). "Cloning and characterization of cDNAs encoding the epsilon-subunit of eukaryotic initiation factor-2B from rabbit and human". Biochim. Biophys. Acta. 1307 (3): 309–17. PMID 8688466.
  • Kimball SR, Heinzinger NK, Horetsky RL, Jefferson LS (1998). "Identification of interprotein interactions between the subunits of eukaryotic initiation factors eIF2 and eIF2B". J. Biol. Chem. 273 (5): 3039–44. PMID 9446619.
  • Welsh GI, Miller CM, Loughlin AJ; et al. (1998). "Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin". FEBS Lett. 421 (2): 125–30. PMID 9468292.
  • Leegwater PA, Könst AA, Kuyt B; et al. (1999). "The gene for leukoencephalopathy with vanishing white matter is located on chromosome 3q27". Am. J. Hum. Genet. 65 (3): 728–34. PMID 10441579.
  • Gomez E, Pavitt GD (2000). "Identification of domains and residues within the epsilon subunit of eukaryotic translation initiation factor 2B (eIF2Bepsilon) required for guanine nucleotide exchange reveals a novel activation function promoted by eIF2B complex formation". Mol. Cell. Biol. 20 (11): 3965–76. PMID 10805739.
  • Anthony TG, Fabian JR, Kimball SR, Jefferson LS (2000). "Identification of domains within the epsilon-subunit of the translation initiation factor eIF2B that are necessary for guanine nucleotide exchange activity and eIF2B holoprotein formation". Biochim. Biophys. Acta. 1492 (1): 56–62. PMID 10858531.
  • Williams DD, Price NT, Loughlin AJ, Proud CG (2001). "Characterization of the mammalian initiation factor eIF2B complex as a GDP dissociation stimulator protein". J. Biol. Chem. 276 (27): 24697–703. doi:10.1074/jbc.M011788200. PMID 11323413.
  • Wang X, Paulin FE, Campbell LE; et al. (2001). "Eukaryotic initiation factor 2B: identification of multiple phosphorylation sites in the epsilon-subunit and their functions in vivo". EMBO J. 20 (16): 4349–59. doi:10.1093/emboj/20.16.4349. PMID 11500362.
  • Leegwater PA, Vermeulen G, Könst AA; et al. (2001). "Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter". Nat. Genet. 29 (4): 383–8. doi:10.1038/ng764. PMID 11704758.
  • Wang X, Janmaat M, Beugnet A; et al. (2002). "Evidence that the dephosphorylation of Ser(535) in the epsilon-subunit of eukaryotic initiation factor (eIF) 2B is insufficient for the activation of eIF2B by insulin". Biochem. J. 367 (Pt 2): 475–81. doi:10.1042/BJ20020677. PMID 12133000.
  • Fogli A, Wong K, Eymard-Pierre E; et al. (2002). "Cree leukoencephalopathy and CACH/VWM disease are allelic at the EIF2B5 locus". Ann. Neurol. 52 (4): 506–10. doi:10.1002/ana.10339. PMID 12325082.
  • Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
  • Fogli A, Dionisi-Vici C, Deodato F; et al. (2003). "A severe variant of childhood ataxia with central hypomyelination/vanishing white matter leukoencephalopathy related to EIF21B5 mutation". Neurology. 59 (12): 1966–8. PMID 12499492.
  • Fogli A, Rodriguez D, Eymard-Pierre E; et al. (2003). "Ovarian failure related to eukaryotic initiation factor 2B mutations". Am. J. Hum. Genet. 72 (6): 1544–50. PMID 12707859.
  • van der Knaap MS, van Berkel CG, Herms J; et al. (2004). "eIF2B-related disorders: antenatal onset and involvement of multiple organs". Am. J. Hum. Genet. 73 (5): 1199–207. PMID 14566705.
  • Ota T, Suzuki Y, Nishikawa T; et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.

Template:WikiDoc Sources